Susvimo 100 mg/mL injection Images
Generic Name: ranibizumab
This medication has been identified as Susvimo 100 mg/mL injection and is used for Macular Degeneration, Diabetic Retinopathy, and Diabetic Macular Edema. It belongs to the drug class anti-angiogenic ophthalmic agents and is not a controlled substance.
Images of medication
Susvimo
- Generic Name
- ranibizumab
- Strength
- 100 mg/mL injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0078
See also:
More about Susvimo (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.